An online prescription service is not one transaction. It is a chain of decisions and handoffs: someone reviews the intake, someone prescribes, a pharmacy prepares or dispenses the medicine, and a team handles questions afterward. Trava Health presents a streamlined version of that journey, advertising injectable semaglutide and tirzepatide alongside monthly and quarterly plans. For a prospective patient, the useful question is not simply whether the website offers treatment, but who takes responsibility at each stage.
This review examines Trava’s public documentation consulted October 19, 2026. The pages describe a Texas-limited service with online assessment, prescription-dependent access, pharmacy fulfillment and recurring subscriptions. They also contain different company and clinical-group names that are not fully reconciled. The result is a documented care pathway with meaningful practical details, but several handoffs that deserve clarification before enrollment, payment or shipment.
At a glance
- Current service area
- The consulted terms limit service to people located in Texas, generally age 18 or older, and require the consultation location to match the shipping-address state.Sources: [2]
- Clinical responsibility
- Trava says it is not a healthcare provider; a patient relationship may instead arise with a medical group or its clinicians.Sources: [2]
- Advertised injection prices
- Homepage starting prices are $88.65 for semaglutide and $147.33 for tirzepatide, without a stated supply period there. Product pages show $117.96 monthly and $178.98 monthly, respectively; pricing varies by prescribed medicine and strength.
- Support and delivery
- Trava advertises a support-team response within 24 hours and free next-day shipping. Neither establishes a clinical-review deadline or a guaranteed arrival date.
- Renewal boundary
- Subscription cancellation requires at least 48 hours before renewal processing. Orders transmitted to and processed by the pharmacy cannot be canceled, modified or refunded.Sources: [2]
Start by identifying the people behind the platform
Trava’s terms identify the operator as Trava Health, Inc. and/or subsidiaries, while its privacy policy uses Trava Health, LLC and affiliates. More important for care delivery, the terms explicitly say Trava is not a healthcare provider. They distinguish the platform relationship from a possible patient relationship with the medical group or individual clinicians. That separation makes the identity of the treating organization a practical enrollment question, not merely a detail in the legal footer.
The homepage presents Wasef Health Partners and names five physicians: Constantin Chikando, MD, in emergency medicine, and James Teet, DO, Michael Wasef, MD, David Wasef, MD, and Andrew Sakla, DO, in internal medicine. The terms instead enumerate You Health medical groups across several states. They also list Beluga Health and GoGoMeds in a footer without clearly explaining their roles. These references do not establish which organization would handle a particular patient’s consultation.
Before proceeding, ask for the treating clinician’s name, professional credential and medical-group affiliation, plus the organization responsible for records and follow-up. This review did not independently verify licenses or board certification; Trava’s statements about those credentials remain provider claims. Our guide to the difference between a platform and a treating clinician explains why the appointment interface and the clinical relationship may belong to different entities.
| Stage | What Trava documents | What to confirm |
|---|---|---|
| Platform access | Trava operates the service but says it is not the healthcare provider. | Which legal entity manages your account and payment? |
| Clinical review | A consultation, suitability decision and prescription are required. | Who is your clinician and medical group? |
| Pharmacy fulfillment | The terms name several fulfillment pharmacies. | Which pharmacy will prepare and dispense your prescription? |
| Shipping | The pricing page advertises free next-day shipping. | When does that clock begin, and who handles delivery problems? |
| Ongoing care | Online follow-ups and a 24-hour support response are advertised. | How are clinical questions routed and follow-up scheduled? |
Check location and access before completing intake
Despite the multistate medical-group list, the consulted availability clause limits service to people located in Texas. It generally requires users to be at least 18, or the age of majority in their home jurisdiction if higher. The terms also require patients to be in the same state as their recorded shipping address when consulting a clinician. A Texas shipping address therefore does not, by itself, resolve access while traveling elsewhere.
The terms contain a narrower exception for ages 13 through 18, but it concerns consultations for acne treatment with topical skincare products and parental consent. It does not document adolescent access to Trava’s GLP-1 offering. For adults, the reviewed pages do not specify GLP-1-specific BMI criteria, required conditions, exclusion criteria or mandatory testing. Those omissions are unanswered enrollment questions, not evidence that Trava has no clinical screening requirements.
The advertised intake asks about health history, lifestyle and goals entirely online. Users must supply compatible equipment, including a computer or mobile device with a video camera and internet access, at their own expense. The documentation does not establish whether every consultation uses video, nor does it confirm Spanish-language care or interpreters. Before sharing information, prepare for the first consultation and ask which records, technology and communication format the assigned clinician requires.
Separate an intake submission from a prescribing decision
Trava says licensed, board-certified providers review every intake. Its terms set out three prerequisites for obtaining a prescription product: completing a consultation, a clinician determining that the product is appropriate, and issuance of a prescription. Completing the questionnaire is therefore not the same as approval. The reviewed documentation does not establish a clinical-review turnaround, so the homepage’s separate support-response promise should not be read as a deadline for a prescription decision.
The product labels identify semaglutide and tirzepatide as weight-loss injections. Trava also publishes a compounded-medication disclosure: these products require prescriptions, are not FDA approved and have not been evaluated by FDA for safety and effectiveness. Its stated condition for compounded preparations is that the prescriber determine a significant difference for the patient compared with the FDA-approved product. The pages do not resolve the exact formulation, added ingredients or preparation assigned to an individual.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality; that fact alone does not establish clinical inequivalence. Trava’s advertising phrase about testing by “FDA labs” is not evidence of product approval or independent verification. Approval concerns a specific drug product, not endorsement of a platform or pharmacy.
Match the prescription to the actual payment
The homepage advertises injectable semaglutide “as low as” $88.65 and injectable tirzepatide “as low as” $147.33. Those blocks do not identify a supply period or the conditions needed to receive the minimum. Separate product pages display semaglutide at $117.96 monthly and tirzepatide at $178.98 monthly. The pricing page explains that medicine and prescribed strength determine price, with lower strengths typically costing less, but the reviewed material does not fully reconcile the displayed amounts.
Trava describes its monthly plan as paying one month at a time and receiving one month of medication. Its quarterly plan provides three months of medication at a time and advertises savings of up to 33%. The product pages separately advertise $87.92 in quarterly-package savings for semaglutide and $94.96 for tirzepatide, without showing the complete quarterly total or clearly selected presentation. These are Trava’s commercial claims, not independently calculated savings or evidence of a minimum commitment.
The pricing page advertises free doctor consultation, ongoing dedicated support, next-day shipping and no add-on fees. The terms say the total subscription price includes platform, pharmacy and medical-group charges as applicable. Still, obtain the exact prescription, amount collected, renewal interval and included services before authorizing payment. Trava advertises HSA/FSA card acceptance without establishing expense eligibility. Its terms exclude participation in federal or state programs, including Medicare and Medicaid; private-insurance coverage and authorization assistance remain unconfirmed.
Find out which pharmacy receives the prescription
The terms name four prescription-fulfillment businesses: Postmeds, Inc., doing business as TruePill; EHT Pharmacy LLC, doing business as Curexa; Apostrophe Pharmacy LLC; and XeCare LLC. The homepage says Trava works with state-licensed pharmacies that compound and dispense in accordance with applicable law and United States Pharmacopeia standards. Those are Trava’s representations. The reviewed pages do not identify which pharmacy would receive a particular semaglutide or tirzepatide prescription, or distinguish each company’s role in that order.
A list of fulfillment partners should not be treated as proof that each listed pharmacy compounds every advertised medicine. Ask which business prepares the product, which dispenses it, and which contact handles label questions or a problematic shipment. The formulation and pharmacy should be clear before fulfillment, especially because Trava’s cancellation restrictions become much tighter after pharmacy processing. Our pharmacy-handoff questions provide a framework for establishing those responsibilities without assuming all steps occur within the platform.
Trava also documents an outside-pharmacy route. If a patient selects a pharmacy outside its listed partners, the service sends the prescription, but the patient must obtain the medicine and pay that pharmacy directly. That materially changes the advertised bundled pathway. The public terms do not explain how an outside fill affects the platform charge, subscription or shipping benefits, so request an itemized explanation rather than assuming the displayed package price follows the prescription.
Treat shipping as a separate clock
Trava’s pricing page advertises free next-day shipping, but the reviewed documentation does not define when that period begins. It does not establish how long clinical review takes, how quickly a pharmacy processes an approved prescription, or when a package will reach the patient. A shipping promise is therefore not a next-day-treatment promise. Ask for separate estimates for prescribing, pharmacy processing, dispatch and arrival, along with tracking and the procedure for a delayed or missing order.
The reviewed material does not detail refrigerated transport, temperature indicators or replacement rules for damaged or inadequately cooled deliveries. FDA explicitly recommends not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That is general regulatory guidance, not a finding about Trava shipments. Establish the appropriate delivery-problem contact in advance, rather than relying on an unspecified support queue after an unexpected arrival.
The terms add a concrete packaging limitation: prescriptions fulfilled by the listed pharmacies do not use child-resistant packaging or containers. That deserves attention when planning receipt and storage, particularly in a household with children. The available documentation did not include expanded shipping-detail content that could resolve other handling questions. Our explanation of approval, dispatch and arrival as different clocks helps put the advertised shipping benefit in its proper place in the overall timeline.
Determine what ongoing support actually delivers
The homepage promises online access to the care team, follow-ups, adjustments and answers when needed. It also says the team responds within 24 hours, including for refill questions and dose-adjustment inquiries. This describes an advertised support response, not necessarily a completed clinical assessment within that period. The reviewed pages do not specify who initially answers, how messages reach the prescriber, whether appointments are scheduled routinely, or what happens when the assigned clinician is unavailable.
There is an important distinction between support being available and follow-up being initiated. Trava’s terms say the platform or clinicians may contact patients for updated information and subscription continuity, but are not required to do so. A patient should therefore ask whether check-ins must be requested, what information is needed before a refill, and whether a clinical review precedes every renewal. Continued billing alone does not document reassessment of treatment response or tolerability.
Information access is another part of continuity. The privacy policy allows a medical-record copy to be requested by email, but says that using that method means agreeing to receive the record through unencrypted email. The terms also caution that HIPAA may not apply to particular transactions or communications involving the service and associated entities. Ask who holds the clinical record, how to obtain it securely and how another treating professional can receive relevant information.
Plan the exit before the next pharmacy handoff
Trava’s homepage says there are no hidden fees or membership traps, but its terms expressly allow automatically renewing subscriptions. The payment method is charged at the intervals presented during checkout until cancellation. To prevent renewal, cancellation must be requested at least 48 hours before the renewal-processing date. The terms allow cancellation through the service, an online account, email or by calling 281-241-9005, with cancellation taking effect at the end of the current subscription period.
Ending future renewals is different from reversing an existing order. Once an order has been transmitted to and processed by the pharmacy, Trava says it cannot be canceled, changed or refunded. Partially used subscription periods are also nonrefundable. Limited exceptions may be considered at Trava’s discretion before pharmacy processing, but are not guaranteed. Ask for the renewal-processing date and written cancellation confirmation; the shipment date is not the only deadline that matters.
The terms also say temporary pauses may be offered, with charges automatically resuming when a pause ends unless the subscription is canceled. A pause is therefore not necessarily a permanent billing stop. Before changing plans, clarify the next charge, any pending pharmacy order and who remains available for clinical questions. The documentation is more explicit about stopping payments than about arranging care after departure, making records access and a continuity plan useful final questions.
Questions & answers
Can I use Trava outside Texas?
The consulted terms currently limit service to people located in Texas. They also require you to be in the same state as your account’s shipping address during consultation. The presence of medical-group names from other states does not establish nationwide availability. Confirm access before enrolling or arranging a consultation while traveling.
Does completing Trava’s questionnaire guarantee a prescription?
No. Trava’s terms require a consultation, a clinician’s determination that the prescription product is appropriate, and an issued prescription. Its online intake is the starting point, not a guaranteed approval. The reviewed pages do not provide a clinical-review deadline or enough provider-specific criteria to determine an individual’s eligibility.
Which Trava price should I expect to pay?
The homepage starting figures are $88.65 for injectable semaglutide and $147.33 for injectable tirzepatide, without a stated supply period there. Product pages show $117.96 and $178.98 monthly, respectively. Trava says medicine and prescribed strength determine pricing. Obtain the exact selected product, plan total, initial collection and recurring charge rather than assuming the lowest headline applies.
Can Trava send my prescription to another pharmacy?
The terms describe that option: the service sends the prescription to your selected outside pharmacy, while you become responsible for obtaining the medicine and paying that pharmacy directly. They do not explain how this changes the bundled subscription charge. Confirm both the pharmacy’s price and any remaining Trava charges before choosing this route.
Does Trava’s 24-hour response promise mean next-day treatment?
No. The promise concerns a support-team response. Free next-day shipping is a separate advertised benefit whose starting point is not defined in the reviewed material. Neither establishes when a clinician will complete review, when a pharmacy will process the prescription or the date treatment will arrive. Request separate timelines for those stages.
If I cancel Trava, will I get a refund?
Cancellation does not imply a refund. Request it at least 48 hours before renewal processing to stop the next renewal. Trava excludes refunds for partially used subscription periods and orders already processed by the pharmacy. Limited discretionary exceptions are only considered before pharmacy processing. Cancellation ordinarily takes effect at the current period’s end.
Our assessment
Trava documents several useful elements of an online GLP-1 pathway: prescription-dependent access, monthly or quarterly medication plans, named fulfillment partners, included support and explicit renewal rules. Its strongest practical limitation is that the public documentation does not fully connect those elements to a specific patient’s clinician, formulation, pharmacy and delivery schedule. The differing corporate and clinical names also merit clarification rather than speculation. For an adult located in Texas, a productive next step is to request a written account of the assigned care team, exact prescription and price, pharmacy contact, delivery process and renewal deadline. Those answers would make the advertised convenience easier to evaluate without treating marketing promises as completed clinical or logistical commitments.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.